21 results on '"Verjans, Eva"'
Search Results
2. Amitriptyline inhibits bronchoconstriction and directly promotes dilatation of the airways
- Author
-
Hempel, Paulina, Klein, Virag, Michely, Anna, Böll, Svenja, Rieg, Annette D., Spillner, Jan, Braunschweig, Till, von Stillfried, Saskia, Wagner, Norbert, Martin, Christian, Tenbrock, Klaus, and Verjans, Eva
- Published
- 2023
- Full Text
- View/download PDF
3. Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca2+-sensitisation
- Author
-
Rieg, Annette D., Suleiman, Said, Anker, Carolin, Bünting, Nina A., Verjans, Eva, Spillner, Jan, Kalverkamp, Sebastian, von Stillfried, Saskia, Braunschweig, Till, Uhlig, Stefan, and Martin, Christian
- Published
- 2022
- Full Text
- View/download PDF
4. Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
- Author
-
Sorg, Anna-Lisa, Bergfeld, Leon, Jank, Marietta, Corman, Victor, Semmler, Ilia, Goertz, Anna, Beyerlein, Andreas, Verjans, Eva, Wagner, Norbert, Von Bernuth, Horst, Lander, Fabian, Weil, Katharina, Hufnagel, Markus, Spiekerkoetter, Ute, Chao, Cho-Ming, Naehrlich, Lutz, Muntau, Ania Carolina, Schulze-Sturm, Ulf, Hansen, Gesine, Wetzke, Martin, Jung, Anna-Maria, Niehues, Tim, Fricke-Otto, Susanne, Von Both, Ulrich, Huebner, Johannes, Behrends, Uta, Liese, Johannes G., Schwerk, Christian, Drosten, Christian, Von Kries, Ruediger, and Schroten, Horst
- Published
- 2022
- Full Text
- View/download PDF
5. Epigenetic Leukocyte Counts from Dried Blood Spots of Pediatric Patients.
- Author
-
Hubens, Wouter, Kluge, Lara, Seitz, Alexander, Verjans, Eva, Rink, Lothar, and Wagner, Wolfgang
- Published
- 2024
- Full Text
- View/download PDF
6. Initiation of LPS-induced pulmonary dysfunction and its recovery occur independent of T cells
- Author
-
Verjans, Eva, Kanzler, Stephanie, Ohl, Kim, Rieg, Annette D., Ruske, Nadine, Schippers, Angela, Wagner, Norbert, Tenbrock, Klaus, Uhlig, Stefan, and Martin, Christian
- Published
- 2018
- Full Text
- View/download PDF
7. PDGF-BB regulates the pulmonary vascular tone: impact of prostaglandins, calcium, MAPK- and PI3K/AKT/mTOR signalling and actin polymerisation in pulmonary veins of guinea pigs
- Author
-
Rieg, Annette D., Suleiman, Said, Anker, Carolin, Verjans, Eva, Rossaint, Rolf, Uhlig, Stefan, and Martin, Christian
- Published
- 2018
- Full Text
- View/download PDF
8. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
- Author
-
Sorg, Anna-Lisa, Becht, Selina, Jank, Marietta, Armann, Jakob, von Both, Ulrich, Hufnagel, Markus, Lander, Fabian, Liese, Johannes G., Niehues, Tim, Verjans, Eva, Wetzke, Martin, Stojanov, Silvia, Behrends, Uta, Drosten, Christian, Schroten, Horst, and von Kries, Rüdiger
- Published
- 2022
- Full Text
- View/download PDF
9. Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca2+-sensitisation.
- Author
-
Rieg, Annette D., Suleiman, Said, Anker, Carolin, Bünting, Nina A., Verjans, Eva, Spillner, Jan, Kalverkamp, Sebastian, von Stillfried, Saskia, Braunschweig, Till, Uhlig, Stefan, and Martin, Christian
- Subjects
PLATELET-derived growth factor ,IDIOPATHIC pulmonary fibrosis ,PROTEIN-tyrosine kinase inhibitors ,POLYMERIZATION ,ACTIN - Abstract
Background: PDGFR-inhibition by the tyrosine kinase inhibitor (TKI) nintedanib attenuates the progress of idiopathic pulmonary fibrosis (IPF). However, the effects of PDGF-BB on the airway tone are almost unknown. We studied this issue and the mechanisms beyond, using isolated perfused lungs (IPL) of guinea pigs (GPs) and precision-cut lung slices (PCLS) of GPs and humans.Methods: IPL: PDGF-BB was perfused after or without pre-treatment with the TKI imatinib (perfused/nebulised) and its effects on the tidal volume (TV), the dynamic compliance (Cdyn) and the resistance were studied.Pcls (gp): The bronchoconstrictive effects of PDGF-BB and the mechanisms beyond were evaluated. PCLS (human): The bronchoconstrictive effects of PDGF-BB and the bronchorelaxant effects of imatinib were studied. All changes of the airway tone were measured by videomicroscopy and indicated as changes of the initial airway area.Results: PCLS (GP/human): PDGF-BB lead to a contraction of airways. IPL: PDGF-BB decreased TV and Cdyn, whereas the resistance did not increase significantly. In both models, inhibition of PDGFR-(β) (imatinib/SU6668) prevented the bronchoconstrictive effect of PDGF-BB. The mechanisms beyond PDGF-BB-induced bronchoconstriction include activation of MAP2K and TP-receptors, actin polymerisation and Ca2+-sensitisation, whereas the increase of Ca2+ itself and the activation of EP1-4-receptors were not of relevance. In addition, imatinib relaxed pre-constricted human airways.Conclusions: PDGFR regulates the airway tone. In PCLS from GPs, this regulatory mechanism depends on the β-subunit. Hence, PDGFR-inhibition may not only represent a target to improve chronic airway disease such as IPF, but may also provide acute bronchodilation in asthma. Since asthma therapy uses topical application. This is even more relevant, as nebulisation of imatinib also appears to be effective. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
10. Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus
- Author
-
Roth Johannes, Wagner Norbert, Maschke-Neuss Karin, Honke Nora, Verjans Eva, Lippe Ralph, Ohl Kim, and Tenbrock Klaus
- Subjects
Pediatrics ,RJ1-570 ,Diseases of the musculoskeletal system ,RC925-935 - Published
- 2011
- Full Text
- View/download PDF
11. Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus
- Author
-
Wagner Norbert, Maschke-Neuss Karin, Honke Nora, Verjans Eva, Lippe Ralph, Ohl Kim, Roth Johannes, and Tenbrock Klaus
- Subjects
Pediatrics ,RJ1-570 ,Diseases of the musculoskeletal system ,RC925-935 - Published
- 2011
- Full Text
- View/download PDF
12. CREMα overexpression decreases IL-2 production, induces a TH17 phenotype and accelerates autoimmunity
- Author
-
Lippe, Ralph, Ohl, Kim, Varga, Georg, Rauen, Thomas, Crispin, Jose C., Juang, Yuang-Taung, Kuerten, Stefanie, Tacke, Frank, Wolf, Marc, Roebrock, Kirsten, Vogl, Thomas, Verjans, Eva, Honke, Nora, Ehrchen, Jan, Foell, Dirk, Skryabin, Boris, Wagner, Norbert, Tsokos, George C., Roth, Johannes, and Tenbrock, Klaus
- Published
- 2012
- Full Text
- View/download PDF
13. Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
- Author
-
Hartmann Arndt, Lennartz Birgitt, Lue Hongqi, Schütz Anke K, Bektas Nuran, Noetzel Erik, Verjans Eva, Dahl Edgar, and Bernhagen Jürgen
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine and mediator of acute and chronic inflammatory diseases. MIF is overexpressed in various tumours and has been suggested as a molecular link between chronic inflammation and cancer. MIF overexpression is observed in breast cancer but its causal role in the development of this tumour entity is unclear. Methods MIF levels in breast cancer cell lines were determined by ELISA and Western blot. CD74 was measured by Western blot, fluorescence microscopy and flow cytometry. Cell proliferation was studied by BrdU incorporation, cell adhesion by Matrigel adhesion assay, and cell invasion by migration assay through Matrigel-coated filters using the Transwell system. MIF expression in primary human breast cancers was measured by tissue microarray and a semi-quantitative immunoreactivity score (IRS) and comparison with histopathological parameters and patient outcome data. Results MIF was abundantly expressed in the non-invasive breast cancer cell lines MDA-MB-468 and ZR-75-1, but not in invasive MDA-MB-231 cells, which in turn expressed higher levels of the MIF-receptor CD74. Stimulation with exogenous MIF led to a dramatic upregulation of MIF secretion (50-fold) in MDA-MB-231 cells. Autocrine MIF promoted tumour cell proliferation, as indicated by blockade of MIF or CD74 in MDA-MB-231 and MDA-MB-468, and MDA-MB-231 invasiveness was enhanced by exogenous MIF. We correlated the expression of MIF with histopathological parameters and patient outcome data, using a tissue microarray of 175 primary invasive breast cancers and 35 normal control tissues. MIF was upregulated in breast cancer versus normal tissue (median IRS = 8 versus 6). MIF expression showed positive correlations with progesterone (p = 0.006) and estrogen (p = 0.028) receptor expression, markers of a favourable prognosis and a negative correlation to tumour size (p = 0.007). In line with these data, disease-specific overall (OS) as well as recurrence-free (RFS) survival was significantly improved in breast cancer patients with abundant cytosolic MIF expression compared to MIF low expressers (5-year OS = 67% versus 50%, p = 0.0019; 5-year RFS = 52% versus 36%, p = 0.0327). Conclusion We conclude that intracellular expression of MIF in breast cancer cells is beneficial, whereas extracellular MIF may play a pro-oncogenic role in promoting breast cancer cell-stroma interactions.
- Published
- 2009
- Full Text
- View/download PDF
14. Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels.
- Author
-
Rieg, Annette Dorothea, Suleiman, Said, Bünting, Nina Andrea, Verjans, Eva, Spillner, Jan, Schnöring, Heike, Kalverkamp, Sebastian, Schröder, Thomas, von Stillfried, Saskia, Braunschweig, Till, Schälte, Gereon, Uhlig, Stefan, and Martin, Christian
- Subjects
LEVOSIMENDAN ,VASCULAR resistance ,LUNGS ,PULMONARY hypertension ,HEMODYNAMICS ,SPRAGUE Dawley rats ,CAPILLARIES ,RATS - Abstract
Introduction: Levosimendan is approved for acute heart failure. Within this context, pulmonary hypertension represents a frequent co-morbidity. Hence, the effects of levosimendan on segmental pulmonary vascular resistance (PVR) are relevant. So far, this issue has been not studied. Beyond that the relaxant effects of levosimendan in human pulmonary vessel are unknown. We addressed these topics in rats' isolated perfused lungs (IPL) and human precision-cut lung slices (PCLS). Material and methods: In IPL, levosimendan (10 μM) was perfused in untreated and endothelin-1 pre-contracted lungs. The pulmonary arterial pressure (P
PA ) was continuously recorded and the capillary pressure (Pcap ) was determined by the double-occlusion method. Thereafter, segmental PVR, expressed as precapillary (Rpre ) and postcapillary resistance (Rpost ) and PVR were calculated. Human PCLS were prepared from patients undergoing lobectomy. Levosimendan-induced relaxation was studied in naïve and endothelin-1 pre-contracted PAs and PVs. In endothelin-1 pre-contracted PAs, the role of K+ -channels was studied by inhibition of KATP -channels (glibenclamide), BKCa 2+ -channels (iberiotoxin) and Kv -channels (4-aminopyridine). All changes of the vascular tone were measured by videomicroscopy. In addition, the increase of cAMP/GMP due to levosimendan was measured by ELISA. Results: Levosimendan did not relax untreated lungs or naïve PAs and PVs. In IPL, levosimendan attenuated the endothelin-1 induced increase of PPA , PVR, Rpre and Rpost . In human PCLS, levosimendan relaxed pre-contracted PAs or PVs to 137% or 127%, respectively. In pre-contracted PAs, the relaxant effect of levosimendan was reduced, if KATP - and Kv -channels were inhibited. Further, levosimendan increased cGMP in PAs/PVs, but cAMP only in PVs. Discussion: Levosimendan reduces rats' segmental PVR and relaxes human PAs or PVs, if the pulmonary vascular tone is enhanced by endothelin-1. Regarding levosimendan-induced relaxation, the activation of KATP - and Kv -channels is of impact, as well as the formation of cAMP and cGMP. In conclusion, our results suggest that levosimendan improves pulmonary haemodynamics, if PVR is increased as it is the case in pulmonary hypertension. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
15. Acid sphingomyelinase regulates TH2 cytokine release and bronchial asthma.
- Author
-
Böll, Svenja, Ziemann, Sebastian, Ohl, Kim, Klemm, Patricia, Rieg, Annette D., Gulbins, Erich, Becker, Katrin Anne, Kamler, Markus, Wagner, Norbert, Uhlig, Stefan, Martin, Christian, Tenbrock, Klaus, and Verjans, Eva
- Subjects
ASTHMA ,SPHINGOMYELINASE ,PATHOLOGY ,BRONCHIAL spasm ,TH2 cells ,BRONCHIECTASIS ,PULMONARY eosinophilia - Abstract
Background: Allergic diseases and especially allergic asthma are widespread diseases with high prevalence in childhood, but also in adults. Acid sphingomyelinase (ASM) is a key regulator of the sphingolipid pathway. Previous studies defined the association of ASM with the pathogenesis of TH1‐directed lung diseases like cystic fibrosis and acute lung injury. Here, we define the role of ASM in TH2‐regulated allergic bronchial asthma. Methods: To determine the role of Asm under baseline conditions, wild‐type (WT) and Asm−/− mice were ventilated with a flexiVent setup and bronchial hyperresponsiveness was determined using acetylcholine. Flow cytometry and cytokine measurements in bronchoalveolar lavage fluid and lung tissue were followed by in vitro TH2 differentiations with cells from WT and Asm−/− mice and blockade of Asm with amitriptyline. As proof of principle, we conducted an ovalbumin‐induced model of asthma in WT‐ and Asm−/− mice. Results: At baseline, Asm−/− mice showed better lung mechanics, but unaltered bronchial hyperresponsiveness. Higher numbers of Asm−/− T cells in bronchoalveolar lavage fluid released lower levels of IL‐4 and IL‐5, and these results were paralleled by decreased production of typical TH2 cytokines in Asm−/− T lymphocytes in vitro. This phenotype could be imitated by incubation of T cells with amitriptyline. In the ovalbumin asthma model, Asm−/− animals were protected from high disease activity and showed better lung functions and lower levels of eosinophils and TH2 cytokines. Conclusion: Asm deficiency could induce higher numbers of TH2 cells in the lung, but those cells release decreased TH2 cytokine levels. Hereby, Asm−/− animals are protected from bronchial asthma, which possibly offers novel therapeutic strategies, for example, with ASM blockade. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis.
- Author
-
Ohl, Kim, Fragoulis, Athanassios, Klemm, Patricia, Baumeister, Julian, Klock, Wiebke, Verjans, Eva, Böll, Svenja, Möllmann, Julia, Lehrke, Michael, Costa, Ivan, Denecke, Bernd, Schippers, Angela, Roth, Johannes, Wagner, Norbert, Wruck, Christoph, and Tenbrock, Klaus
- Subjects
SUPPRESSOR cells ,SEPSIS ,OXIDATIVE stress - Abstract
Arising in inflammatory conditions, myeloid-derived suppressor cells (MDSCs) are constantly confronted with intracellular and extracellular reactive oxygen species molecules and oxidative stress. Generating mice with a constitutive activation of Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) we show a pivotal role of the antioxidant stress defense for development of these immune-modulatory cells. These mice are characterized by a massive increase of splenic CD11b
+ Gr-1+ cells, which exhibit typical suppressive characteristics of MDSCs. Whole transcriptome analysis revealed Nrf2-dependent activation of cell cycle and metabolic pathways, which resemble pathways in CD11b+ Gr-1+ MDSCs expanded byin vivo LPS exposure. Constitutive Nrf2 activation thereby regulates activation and balance between glycolysis and mitochondrial metabolism and hence expansion of highly suppressive MDSCs, which mediate protection in LPS-induced sepsis. Our study establishes Nrf2 as key regulator of MDSCs and acquired tolerance against LPS-induced sepsis. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
17. CD11c.DTR mice develop a fatal fulminant myocarditis after local or systemic treatment with diphtheria toxin.
- Author
-
Männ, Linda, Kochupurakkal, Nora, Martin, Christian, Verjans, Eva, Klingberg, Anika, Sody, Simon, Kraus, Andreas, Dalimot, Jill, Bergmüller, Eileen, Jung, Steffen, Voortman, Sylvia, Winterhager, Elke, Brandau, Sven, Garbi, Natalio, Kurrer, Michael, Eriksson, Urs, Gunzer, Matthias, and Hasenberg, Mike
- Abstract
To assess the role of alveolar macrophages (AMs) during a pulmonary Aspergillus fumigatus infection AMs were depleted by intratracheal application of diphtheria toxin (DTX) to transgenic CD11c.DTR mice prior to fungal infection. Unexpectedly, all CD11c.DTR mice treated with DTX died within 4-5 days, whether being infected with A. fumigatus or not. Despite measurable impact of DTX on lung functional parameters, these constrictions could not explain the high mortality rate. Instead, DTX-treated CD11c.DTR animals developed fulminant myocarditis (FM) characterized by massive leukocyte infiltration and myocardial cell destruction, including central parts of the heart's stimulus transmission system. In fact, standard limb lead ECG recordings of diseased but not healthy mice showed a 'Brugada'-like pattern with an abnormally high ST segment pointing to enhanced susceptibility for potential lethal arrhythmias. While CD11c.DTR mice are extensively used for the characterization of CD11c
+ cells, including dendritic cells, several studies have already mentioned adverse side effects following DTX treatment. Our results demonstrate that this limitation is based on severe myocarditis but not on the expected lung constrictions, and has to be taken into consideration if this animal model is used. Based on these properties, however, the CD11c.DTR mouse might serve as useful animal model for FM. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
18. Milrinone Relaxes Pulmonary Veins in Guinea Pigs and Humans.
- Author
-
Rieg, Annette D., Suleiman, Said, Perez-Bouza, Alberto, Braunschweig, Till, Spillner, Jan W., Schröder, Thomas, Verjans, Eva, Schälte, Gereon, Rossaint, Rolf, Uhlig, Stefan, and Martin, Christian
- Subjects
PULMONARY hypertension treatment ,PULMONARY veins ,MILRINONE ,GUINEA pigs as laboratory animals ,PHOSPHODIESTERASE inhibitors ,CELLULAR signal transduction ,HEART failure treatment - Abstract
Introduction: The phosphodiesterase-III inhibitor milrinone improves ventricular contractility, relaxes pulmonary arteries and reduces right ventricular afterload. Thus, it is used to treat heart failure and pulmonary hypertension (PH). However, its action on pulmonary veins (PVs) is not defined, although particularly PH due to left heart disease primarily affects the pulmonary venous bed. We examined milrinone-induced relaxation in PVs from guinea pigs (GPs) and humans. Material and Methods: Precision-cut lung slices (PCLS) were prepared from GPs or from patients undergoing lobectomy. Milrinone-induced relaxation was studied by videomicroscopy in naïve PVs and in PVs pre-constricted with the ET
A -receptor agonist BP0104. Baseline luminal area was defined as 100%. Intracellular cAMP was measured by ELISA and milrinone-induced changes of segmental vascular resistances were studied in the GP isolated perfused lung (IPL). Results: In the IPL (GP), milrinone (10 µM) lowered the postcapillary resistance of pre-constricted vessels. In PCLS (GP), milrinone relaxed naïve and pre-constricted PVs (120%) and this relaxation was attenuated by inhibition of protein kinase G (KT 5823), adenyl cyclase (SQ 22536) and protein kinase A (KT 5720), but not by inhibition of NO-synthesis (L-NAME). In addition, milrinone-induced relaxation was dependent on the activation of KATP -, BKCa 2+ - and Kv -channels. Human PVs also relaxed to milrinone (121%), however only if pre-constricted. Discussion: Milrinone relaxes PVs from GPs and humans. In GPs, milrinone-induced relaxation is based on KATP -, BKCa 2+ - and Kv -channel-activation and on cAMP/PKA/PKG. The relaxant properties of milrinone on PVs lead to reduced postcapillary resistance and hydrostatic pressures. Hence they alleviate pulmonary edema and suggest beneficial effects of milrinone in PH due to left heart disease. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
19. Overexpression of CREMα in T Cells Aggravates Lipopolysaccharide-Induced Acute Lung Injury.
- Author
-
Verjans, Eva, Kim Oh, Yin Yu, Lippe, Ralph, Schippers, Angela, Wiener, Anastasia, Roth, Johannes, Wagner, Norbert, Uhlig, Stefan, Tenbrock, Klaus, and Martin, Christian
- Subjects
- *
T cells , *LUNG injuries , *IMMUNOREGULATION , *TRANSCRIPTION factors , *CYCLIC adenylic acid , *GENETIC overexpression , *PHYSIOLOGY - Abstract
Transcription factor cAMP response element modulator (CREM)α contributes to various cellular and molecular abnormalities in T cells, including increased IL-17 and decreased IL-2 expression. For development of acute lung injury (ALI), the invasion and regulation of immune cells are highly important, but the role of T cells remains unclear. In this study, we show that CREMα is upregulated in LPS-induced ALI. During the early phase of ALI (day 1), T cell–specific CREMα overexpression enhances the numbers of T cells and expression of TNF-α in bronchoalveolar lavage fluid and deteriorates lung functions. On day 3 of ALI, CREMα transgenic mice present a stronger inflammatory response with higher levels of TNF-α, IL-6, and IL-17 correlating with increased numbers of T cells and neutrophils in bronchoalveolar lavage fluid, whereas expression of Foxp3 and IL-2 and numbers of regulatory T cells are decreased. These changes result in restricted lung function in CREMα transgenic mice. Finally, an adoptive transfer of CREM−/− CD4+ T cells, but not of wild-type T cells into RAG-1−/− mice results in ameliorated disease levels. Thus, levels of CREM in T cells determine the outcome of ALI, and CREMα transgenic animals represent a model in which proinflammatory T cells aggravate ALI in different phases of the disease. Given the fact that patients with autoimmune diseases like systemic lupus erythematosus show higher levels of CREMα and an increased susceptibility toward infectious complications, our finding is of potential clinical significance and may enable new therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
20. Levosimendan Relaxes Pulmonary Arteries and Veins in Precision-Cut Lung Slices - The Role of KATP-Channels, cAMP and cGMP.
- Author
-
Rieg, Annette D., Rossaint, Rolf, Verjans, Eva, Maihöfer, Nina A., Uhlig, Stefan, and Martin, Christian
- Subjects
PULMONARY artery physiology ,ADENOSINE triphosphate ,POTASSIUM channels ,ADENOSINE monophosphate ,CYCLIC guanylic acid ,ENZYME-linked immunosorbent assay ,ENDOTHELIN receptors - Abstract
Introduction: Levosimendan is approved for left heart failure and is also used in right heart failure to reduce right ventricular afterload. Despite the fact that pulmonary arteries (PAs) and pulmonary veins (PVs) contribute to cardiac load, their responses to levosimendan are largely unknown. Materials and Methods: Levosimendan-induced vasorelaxation of PAs and PVs was studied in precision-cut lung slices from guinea pigs by videomicroscopy; baseline luminal area was defined as 100%. Intracellular cAMP- and cGMP-levels were measured by ELISA and NO end products were determined by the Griess reaction. Results: Levosimendan relaxed control PVs (116%) and those pre-constricted with an endothelin
A -receptor agonist (119%). PAs were only relaxed if pre-constricted (115%). Inhibition of KATP -channels (glibenclamide), adenyl cyclase (SQ 22536) and protein kinase G (KT 5823) largely attenuated the levosimendan-induced relaxation in control PVs, as well as in pre-constricted PAs and PVs. Inhibition of BKCa 2+ -channels (iberiotoxin) and Kv -channels (4-aminopyridine) only contributed to the relaxant effect of levosimendan in pre-constricted PAs. In both PAs and PVs, levosimendan increased intracellular cAMP- and cGMP-levels, whereas NO end products remained unchanged. Notably, basal NO-levels were higher in PVs. The KATP -channel activator levcromakalim relaxed PAs dependent on cAMP/PKA/PKG and increased cAMP-levels in PAs. Discussion: Levosimendan initiates complex and divergent signaling pathways in PAs and PVs. Levosimendan relaxes PAs and PVs primarily via KATP -channels and cAMP/cGMP; in PAs, BKCa 2+ - and Kv -channels are also involved. Our findings with levcromakalim do further suggest that in PAs the activation of KATP -channels leads to the production of cAMP/PKA/PKG. In conclusion, these results suggest that levosimendan might reduce right ventricular afterload by relaxation of PAs as well as pulmonary hydrostatic pressure and pulmonary edema by relaxation of PVs. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
21. Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
- Author
-
Verjans E, Noetzel E, Bektas N, Schütz AK, Lue H, Lennartz B, Hartmann A, Dahl E, Bernhagen J, Verjans, Eva, Noetzel, Erik, Bektas, Nuran, Schütz, Anke K, Lue, Hongqi, Lennartz, Birgitt, Hartmann, Arndt, Dahl, Edgar, and Bernhagen, Jürgen
- Abstract
Background: Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine and mediator of acute and chronic inflammatory diseases. MIF is overexpressed in various tumours and has been suggested as a molecular link between chronic inflammation and cancer. MIF overexpression is observed in breast cancer but its causal role in the development of this tumour entity is unclear.Methods: MIF levels in breast cancer cell lines were determined by ELISA and Western blot. CD74 was measured by Western blot, fluorescence microscopy and flow cytometry. Cell proliferation was studied by BrdU incorporation, cell adhesion by Matrigel adhesion assay, and cell invasion by migration assay through Matrigel-coated filters using the Transwell system. MIF expression in primary human breast cancers was measured by tissue microarray and a semi-quantitative immunoreactivity score (IRS) and comparison with histopathological parameters and patient outcome data.Results: MIF was abundantly expressed in the non-invasive breast cancer cell lines MDA-MB-468 and ZR-75-1, but not in invasive MDA-MB-231 cells, which in turn expressed higher levels of the MIF-receptor CD74. Stimulation with exogenous MIF led to a dramatic upregulation of MIF secretion (50-fold) in MDA-MB-231 cells. Autocrine MIF promoted tumour cell proliferation, as indicated by blockade of MIF or CD74 in MDA-MB-231 and MDA-MB-468, and MDA-MB-231 invasiveness was enhanced by exogenous MIF. We correlated the expression of MIF with histopathological parameters and patient outcome data, using a tissue microarray of 175 primary invasive breast cancers and 35 normal control tissues. MIF was upregulated in breast cancer versus normal tissue (median IRS = 8 versus 6). MIF expression showed positive correlations with progesterone (p = 0.006) and estrogen (p = 0.028) receptor expression, markers of a favourable prognosis and a negative correlation to tumour size (p = 0.007). In line with these data, disease-specific overall (OS) as well as recurrence-free (RFS) survival was significantly improved in breast cancer patients with abundant cytosolic MIF expression compared to MIF low expressers (5-year OS = 67% versus 50%, p = 0.0019; 5-year RFS = 52% versus 36%, p = 0.0327).Conclusion: We conclude that intracellular expression of MIF in breast cancer cells is beneficial, whereas extracellular MIF may play a pro-oncogenic role in promoting breast cancer cell-stroma interactions. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.